Search for Clinical Trial Results

Sponsored By

Adult-onset Still's Disease - 5 Studies Found

Status Study
Recruiting Study Name: Canakinumab for Treatment of Adult Onset Still's Disease
Condition: Adult-Onset Still´s Disease
Date: 2014-07-29
Interventions:
  • Drug: Canakinumab Canakinumab

Completed Study Name: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
Condition: Adult-Onset Still's Disease
Date: 2009-12-15
Interventions:
  • Drug: anakinra 100 mg subcutan
Completed Study Name: Efficacy and Safety of Tocilizumab in Adult's Still Disease
Condition: Adult's Still Disease
Date: 2009-10-26
Interventions: Drug: Tocilizumab Tocilizumab, IV, 8 mg/kg, every 2 weeks
Completed Study Name: Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
Condition: Still's Disease, Adult-Onset
Date: 2015-02-23
Interventions: Biological: Tadekinig alfa (recombinant human IL-18 binding protein) Patients received the study treatme
Completed Study Name: Interleukin-1 Trap to Treat Autoinflammatory Diseases
Condition:
  • Inflammation
  • Familial Mediterranean Fever
  • Still's Disease,
    Date: 2004-10-28
    Interventions: Drug: IL-1 Trap